formycin triphosphate has been researched along with staurosporine in 1 studies
| Studies (formycin triphosphate) | Trials (formycin triphosphate) | Recent Studies (post-2010) (formycin triphosphate) | Studies (staurosporine) | Trials (staurosporine) | Recent Studies (post-2010) (staurosporine) |
|---|---|---|---|---|---|
| 29 | 0 | 0 | 6,272 | 58 | 976 |
| Protein | Taxonomy | formycin triphosphate (IC50) | staurosporine (IC50) |
|---|---|---|---|
| Chain A, Ribosomal protein S6 kinase alpha-1 | Homo sapiens (human) | 0.0003 | |
| Chain X, Tyrosine-protein kinase Lyn | Homo sapiens (human) | 0.0013 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Assefa, D; Skoglund, G; Worku, Y | 1 |
1 other study(ies) available for formycin triphosphate and staurosporine
| Article | Year |
|---|---|
Protein kinase activities in Leishmania aethiopica: control by growth, transformation and inhibitors.
Topics: Alkaloids; Animals; Formycins; Histones; Humans; Leishmania; Leishmaniasis, Cutaneous; Protamines; Protein Kinase Inhibitors; Protein Kinases; Ribonucleotides; Solubility; Staurosporine; Subcellular Fractions; Substrate Specificity | 1995 |